Status:
COMPLETED
Observational Study on Characteristics and Survival Correlates of Progressive Multifocal Leukoencephalopathy (PML) in Italy
Lead Sponsor:
Scientific Institute San Raffaele
Conditions:
Progressive Multifocal Leukoencephalopathy
PML
Eligibility:
All Genders
Brief Summary
The goal of this observational study is to learn about the features of Progressive Multifocal Leukoencephalopathy (PML) at the time of its diagnosis and the factors that may influence the outcome of p...
Detailed Description
This is a retrospective observational study that investigates the features and the correlates of survival of patients with Progressive Multifocal Leukoencephalopathy (PML). The study is based on demog...
Eligibility Criteria
Inclusion
- Definitive PML diagnosis by either JCV-DNA identification in the cerebrospinal fluid (CSF) or biopsy/autopsy, or a possible diagnosis based on clinico-radiological data, following revision of magnetic resonance imaging (MRI) exams by a PML expert neuroradiologist
- Known year of PML diagnosis
- Known underlying condition predisposing to PML development
Exclusion
- Missing all of the three above-mentioned inclusion criteria
Key Trial Info
Start Date :
January 1 1987
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
456 Patients enrolled
Trial Details
Trial ID
NCT06594614
Start Date
January 1 1987
End Date
April 30 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Raffaele Scientific Institute
Milan, MI, Italy, 20127